10x Genomics, Inc. provided revenue guidance for the full year 2024. 10x Genomics expects full year 2024 revenue to be in the range of $670 million to $690 million, representing 8% to 12% growth over full year 2023 revenue.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.61 USD | +0.47% | -2.64% | -50.59% |
May. 02 | North American Morning Briefing : Stock Futures -2- | DJ |
May. 01 | UBS Adjusts 10x Genomics Price Target to $30 From $52, Maintains Neutral Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.59% | 3.29B | |
-1.74% | 12.56B | |
-9.59% | 7.68B | |
-0.06% | 5.29B | |
+24.50% | 5.24B | |
+0.02% | 4.57B | |
+6.42% | 2.6B | |
-7.60% | 2.2B | |
-8.29% | 1.79B | |
+4.65% | 1.62B |
- Stock Market
- Equities
- TXG Stock
- News 10x Genomics, Inc.
- 10X Genomics, Inc. Provides Revenue Guidance for the Full Year 2024